Evidence map›Paper›PMID 41512056›Full record

ArticleScience advances2026

Impaired nitrogenous waste clearance promotes hepatocellular carcinoma.

Xinlu Han, Jianliang Shen, Junrong Yan, Rahul Tacke, Weiwei Dai, Qingqing Mao, Heineken Queen Daguplo, Shuyang Liu, Ariful Islam, Tong Liu and 12 more

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Xinlu HanDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.ORCID 0009-0006-4826-0794
Jianliang ShenDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.ORCID 0009-0008-5474-7405
Junrong YanDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.
Rahul TackeDepartment of Genetics and Human Genetics Institute of New Jersey, Rutgers University, Piscataway, NJ 08854, USA.
Weiwei DaiDepartment of Biosciences and Bioinformatics, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu, China.
Qingqing MaoRutgers Cancer Institute, New Brunswick, NJ 08903, USA.
Heineken Queen DaguploDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.ORCID 0000-0002-3669-1144
Shuyang LiuDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.
Ariful IslamCenter for Advanced Metabolomics and Proteomics Research & Department of Microbiology, Biochemistry, and Molecular Genetics, Rutgers University-New Jersey Medical School, Newark, NJ 07103, USA.
Tong LiuCenter for Advanced Metabolomics and Proteomics Research & Department of Microbiology, Biochemistry, and Molecular Genetics, Rutgers University-New Jersey Medical School, Newark, NJ 07103, USA.
Mark C KochDepartment of Physiology and Biophysics, Stony Brook University, Stony Brook, NY 11794, USA.ORCID 0009-0008-0029-4068
Richard Z LinDepartment of Physiology and Biophysics, Stony Brook University, Stony Brook, NY 11794, USA.ORCID 0000-0002-3967-0859
Hong LiCenter for Advanced Metabolomics and Proteomics Research & Department of Microbiology, Biochemistry, and Molecular Genetics, Rutgers University-New Jersey Medical School, Newark, NJ 07103, USA.ORCID 0000-0001-5731-5335
Tracy AnthonyDepartment of Nutritional Science, Rutgers University, New Brunswick, NJ 08901, USA.ORCID 0000-0002-8586-5884
Ping XieDepartment of Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ 08854, USA.ORCID 0000-0002-7338-3730
Lanjing ZhangDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.ORCID 0000-0001-5436-887X
Shenglan GaoDepartment of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.ORCID 0009-0005-5991-4899
M Celeste SimonAbramson Family Cancer Research Institute, Department of Cell and Development Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0001-9106-447X
Xin ChenCancer Biology Program, University of Hawaii Cancer Center, Honolulu, HI 96813, USA.ORCID 0000-0002-9588-0164
Jiekun YangDepartment of Genetics and Human Genetics Institute of New Jersey, Rutgers University, Piscataway, NJ 08854, USA.ORCID 0000-0003-0920-052X
Xiaoyang SuRutgers Cancer Institute, New Brunswick, NJ 08903, USA.ORCID 0000-0001-8081-1396
Wei-Xing ZongDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.ORCID 0000-0002-3129-8220

Funding

Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease ProgressionR35CA220483 · NCI · UNIVERSITY OF PENNSYLVANIA · PI M. CELESTE SIMON · 2017 to 2026
$9.4M
Protein and redox homeostasis in cancer development and therapyR01CA129536 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI ZONG, WEI-XING · 2008 to 2022
$4.8M
Glutamine synthetase in cancer cell metabolism and oncogenesisR01CA224550 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI Wei-Xing Zong · 2018 to 2026
$4.7M
Defective urea cycle promotes oncogenesis of hepatocellular carcinomaR01CA286043 · NCI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Wei-Xing Zong · 2024 to 2026
$2.3M
An Orbitrap Astral Mass Spectrometer for Elevating Proteomics Sensitivity at Rutgers Biomedical and Health Sciences Newark CampusS10OD038256 · OD · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI LI, HONG · 2025 to 2025
$2.0M
PI3 kinase PIK3CB (p110beta) in membrane trafficking and metabolismR01CA232246 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI ZONG, WEI-XING · 2018 to 2022
$1.8M
Bruker timsTOF HT Mass Spectrometer for Accelerating Proteomics Research at Rutgers Newark CampusS10OD034300 · OD · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI LI, HONG · 2024 to 2024
$1.1M
NCI NIH HHS R01 CA129536NCI NIH HHS R01 CA224550NCI NIH HHS R01 CA232246NCI NIH HHS R01 CA286043NCI NIH HHS R35 CA220483NIH HHS S10 OD034300NIH HHS S10 OD038256
6 · The paper itself

Abstract

In mammals, hepatic urea cycle enzymes (UCEs) convert ammonia, the toxic nitrogenous waste, into urea for excretion. In hepatocellular carcinoma (HCC), UCE expression is often heterogeneously repressed, but its role in tumorigenesis is unclear. We show that, as in patients, UCE expression is markedly reduced in multiple HCC mouse models, including those driven by oncogenic c-MET/β-catenin, leading to impaired ammonia clearance, altered amino acid metabolism, and increased pyrimidine synthesis. In contrast, UCE expression is largely preserved in c-MET/sgAxin1 tumors, allowing assessment of the consequences of UCE loss. Silencing individual UCEs increases ammonia burden and accelerates HCC with reprogrammed amino acid and pyrimidine metabolism, supporting a causal role for defective ammonia detoxification in oncogenesis. Notably, dietary protein restriction lowers hepatic ammonia and slows tumor growth. These findings establish a mechanistic link between nitrogen overload and hepatocarcinogenesis and highlight protein restriction as a feasible therapeutic strategy for patients with impaired nitrogenous waste handling.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsNitrogenAmino AcidsAmmoniaAnimalsDisease Models, AnimalHumansMiceProto-Oncogene Proteins c-metUreaAmino AcidsAmmoniaNitrogenProto-Oncogene Proteins c-metUrea

Identifiers

PMID41512056
PMCPMC12787525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.